Maiwald Magazine

Press Coverage

22 May 2024 - Press Coverage

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

Deal provides Cytokinetics with diversified access to capital as company advances its specialty cardiology franchise NEW YORK, NY and SOUTH SAN FRANCISCO, CA, May 22, 2024 – Royalty Phar...

9 May 2024 - Press Coverage

Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab

Frexalimab is in Phase 3 development by Sanofi in multiple sclerosis with multi-blockbuster potential in a wide range of immune-mediated diseases Expands Royalty Pharma’s ...

12 Mar 2024 - Press Coverage

The UPC has become known for its expeditious decision-making processes

The UPC has become known for its expeditious decision-making processes. Just how expeditious it can be, has been shown in a recent case filed with the Munich local division against one of our clients. After a quick review of the claimant’s statement of claim, we infor...

Maiwald in the press

Publications

4 Jul 2024 - Publication

Is the medical use disclosure standard different for novelty and sufficiency?, Managing IP, 2024

Eva Ehlich and Anja Fux of Maiwald discuss an EPO board ruling ...

5 Jun 2024 - Publication

Promoting women and young talent at MAIWALD, 2024

Maiwald, a leading German IP law firm, has 45% female partners, emphasizing equality and diversity. The firm supports women's career advancement and attracts talented women th...

3 Jun 2024 - Publication

Offshore wind power and territoriality principles from a German viewpoint

Claus Schindele considers the legal complications regarding patent protection in the offshore wind sector, with a particular eye on Germany and the UK

All publications

Events

Thu.

22 Aug 2024 |Upcoming|External Events

Maiwald at The China Intellectual Property & Innovation Summit (CIPIS) in Shenzhen, August 22 & 23, 2024

The China Intellectual Property & Innovation Summit (CIPIS), organized by Conways, will be held in China for the 20th time in 2024. CIPIS is one of the most influential IP industry events in the Asia-pacific region. The theme of CIPIS is "Global Vision-China Focus". The organizer focuses on in-depth discussions, collisions of ideas, a...

Tue.

24 Sep 2024 |Upcoming|External Events

Maiwald will be represented at WindEnergy Hamburg!

WindEnergy Hamburg is much more than just a trade fair. It not only covers the entire wind energy value chain, but also offers special expertise with its focus on storage technologies. It also offers you an extensive program and a lot of added value, such as the synergy with the world's leading trade fair for the maritime industry, SMM, which takes place shortly before Win...

Tue.

8 Oct 2024 |Upcoming|External Events

Maiwald is partner of the 3rd Annual Life Science Strategy Summit on IP & Exclusivity from October 8-10 in Munich

We are delighted to support the third annual Life Science Strategy Summit on IP & Exclusivity as a Platinum Partner! This industry-leading life science legal event brings together the leading pharma and biotech experts for three days of practical discussion on the protection of pharm...

Wed.

9 Oct 2024 |Upcoming|Seminar

Maiwald at BioTechX Europe 2024, October 9-10

BioTechX Europe is Europe's largest congress for diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare. In October, the three-day event returns to Basel, the pharmaceutical center of Europe, with over 3,500 leading industry representatives, 400 speakers and 50 start-ups u...

All events

News and Releases

Maiwald Blog

The road to G1/23 “solar cell” – Determining the fate of commercial polymer products as prior art

Dr. Michaela Weigel-Krusemarck on current developments in formal priority law

One year Unitary Patent and Unified Patent Court in facts and figures

Press Coverage

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab

The UPC has become known for its expeditious decision-making processes

Staff News

Maiwald appoints Dr. Michaela Weigel-Krusemarck and Dr. Andreas Eisele as partners

Dr. Kerstin Wolff and Tobias Matschke promoted to Counsel at Maiwald

Maiwald congratulates Anja Fux on a very successful year 2023

Publications

Is the medical use disclosure standard different for novelty and sufficiency?, Managing IP, 2024

Promoting women and young talent at MAIWALD, 2024

Offshore wind power and territoriality principles from a German viewpoint

Awards

IP STARS Top Tier Firm rankings 2024 for patent disputes, protection work and trade mark

Leaders League Rankings Germany 2024

Handelsblatt Best Lawyers: Germany’s Best Lawyers 2024

Events

Maiwald at The China Intellectual Property & Innovation Summit (CIPIS) in Shenzhen, August 22 & 23, 2024

Maiwald will be represented at WindEnergy Hamburg!

Maiwald is partner of the 3rd Annual Life Science Strategy Summit on IP & Exclusivity from October 8-10 in Munich

Maiwald at BioTechX Europe 2024, October 9-10